A budget provision protecting genetically-modified seeds from litigation in the face of health risks was extended for three months in an approved US House of Representatives’ spending bill on Tuesday evening.
Called “The Monsanto Protection Act” by opponents, the
budget rider shields biotech behemoths like Monsanto, Cargill and
others from the threat of lawsuits and bars federal courts from
intervening to force an end to the sale of a GMO
(genetically-modified organism) even if the
genetically-engineered product causes damaging health effects.
The biotech rider first made news in March when it was a last-minute addition to the successfully-passed House Agriculture Appropriations Bill for 2013, a short-term funding bill that was approved to avoid a federal government shutdown.
The current three-month extension is part of the short-term FY14 Continuing Resolution spending bill.
The Center for Food Safety, a vocal opponent of the rider, released a statement expressing dismay that the measure once again avoided proper legislative process while usurping the power to challenge GMO products in court.
“The rider represents an unprecedented attack on US judicial review, which is an essential element of US law and provides a critical check on government decisions that may negatively impact human health, the environment or livelihoods,” they wrote. “This also raises potential jurisdictional concerns with the Senate Agriculture and Judiciary Committees that merited hearings by the Committees before its consideration.”
Following the original vote in March, President Barack Obama signed the provision into law as part of larger legislation to avoid a government shutdown. Rallies took place worldwide in May protesting the clandestine effort to protect the powerful companies from judicial scrutiny.
“It is extremely disappointing to see the damaging ‘Monsanto Protection Act’ policy rider extended in the House spending bill,” said Colin O’Neil, director of government affairs for Center for Food Safety. “Hundreds of thousands of Americans called their elected officials to voice their frustration and disappointment over the inclusion of ‘Monsanto Protection Act’ this past spring. Its inclusion is a slap in the face to the American public and our justice system.”
Largely as a result of prior lawsuits, the US Department of Agriculture (USDA) is required to complete environmental impact statements (EIS) to assess risk prior to both the planting and sale of GMO crops. The extent and effectiveness to which the USDA exercises this rule is in itself a source of serious dispute.
The reviews have been the focus of heated debate between food safety advocacy groups and the biotech industry in the past. In December of 2009, for example, Food Democracy Now collected signatures during the EIS commenting period in a bid to prevent the approval of Monsanto’s GMO alfalfa, which many feared would contaminate organic feed used by dairy farmers; it was approved regardless.
The biotech rider “could override any court-mandated caution and could instead allow continued planting. Further, it forces USDA to approve permits for such continued planting immediately, putting industry completely in charge by allowing for a ‘back door approval’ mechanism,” the Center for Food Safety said.